Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 89, Issue 6, Pages 924-927Publisher
WILEY
DOI: 10.1038/clpt.2011.18
Keywords
-
Categories
Ask authors/readers for more resources
Our knowledge regarding genetic factors that affect drug effectiveness and adverse drug reactions is continuously increasing, and a growing number of pharmacogenetic gene-drug interactions are included in drug labels. Nevertheless, the uptake of this important information into clinical practice has been minimal. The development of concise, evidence-based clinical practice guidelines (CPGs) on pharmacogenetic testing is urgently needed to overcome the barriers hindering clinical implementation by providing guidance on test use and interpretation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available